107.521 articles found

Isolated neuronal cell material free of glial cells, useful for transplantation, e.g. to treat Parkinson's disease

Check source for author details

· 1999-06-19

Medical progress. New hope for Parkinson's treatments.

Check source for author details

Harv Health Lett · 1999-06-01

PMID: 10233793

Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson's disease.

Lekwuwa GU, Barnes GR, Collins CJ, Limousin P.

J Neurol Neurosurg Psychiatry · 1999-06-01

DOI: 10.1136/jnnp.66.6.746PMID: 10329748

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease.

Ito K, Morrish PK, Rakshi JS, Uema T, Ashburner J, Bailey DL, Friston KJ, Brooks DJ.

J Neurol Neurosurg Psychiatry · 1999-06-01

DOI: 10.1136/jnnp.66.6.754PMID: 10329749

Developmental stuttering and Parkinson's disease: the effects of levodopa treatment.

Anderson JM, Hughes JD, Rothi LJ, Crucian GP, Heilman KM.

J Neurol Neurosurg Psychiatry · 1999-06-01

DOI: 10.1136/jnnp.66.6.776PMID: 10329754

Prefrontal dysfunction following unilateral posteroventral pallidotomy in Parkinson's disease.

Yokoyama T, Imamura Y, Sugiyama K, Nishizawa S, Yokota N, Ohta S, Uemura K.

J Neurosurg · 1999-06-01

DOI: 10.3171/jns.1999.90.6.1005PMID: 10350244

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.

Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Björklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O.

Brain · 1999-06-01

DOI: 10.1093/brain/122.6.1121PMID: 10356064

From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation.

Nasreddine ZS, Loginov M, Clark LN, Lamarche J, Miller BL, Lamontagne A, Zhukareva V, Lee VM, Wilhelmsen KC, Geschwind DH.

Ann Neurol · 1999-06-01

DOI: 10.1002/1531-8249(199906)45:6<704::aid-ana4>3.0.co;2-xPMID: 10360762

ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.

Rascol O, Blin O, Thalamas C, Descombes S, Soubrouillard C, Azulay P, Fabre N, Viallet F, Lafnitzegger K, Wright S, Carter JH, Nutt JG.

Ann Neurol · 1999-06-01

DOI: 10.1002/1531-8249(199906)45:6<736::aid-ana7>3.0.co;2-fPMID: 10360765

Development of a clinical rating scale for persons with Parkinson's disease.

Cutson TM, Sloane R, Schenkman M.

J Am Geriatr Soc · 1999-06-01

DOI: 10.1111/j.1532-5415.1999.tb01608.xPMID: 10366184

Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Matsumura N, Yamazaki T, Ihara Y.

Am J Pathol · 1999-06-01

DOI: 10.1016/s0002-9440(10)65420-xPMID: 10362789

Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease.

Akhmedova S, Anisimov S, Yakimovsky A, Schwartz E.

Hum Hered · 1999-06-01

DOI: 10.1159/000022868PMID: 10364684